Although these studies indicate that GPR158 may exhibit contrasting roles in different types of neurocytomas, either promoting or inhibiting tumor progression, this does not diminish the potential of the OCN/GPR158 axis as a crucial biomarker for diagnosing neurological diseases. The gene discussed is GPR158; the disease is central neurocytoma.